Blog Search

Genomic sequencing at Netflix prices

Human Longevity, Inc. will offer exome sequencing to consumers for $250. That's about the price of a Netflix account (including DVDs) When personalized medicine goes commercial, health care will be transformed in ways we can't imagine http://bit…
http://mylifeisworthit.org/blog/2015/09/genomic-sequencing-netflix-prices/

Drug Goes From $13.50 a Tablet to $750, Overnight

Specialists in infectious disease are protesting a gigantic overnight increase in the price of a 62-year-old drug that is the standard of care for treating a life-threatening parasitic infection.
The drug, called Daraprim, was acquired in August by Turing Pharmaceuticals, a start-up run by a former hedge fund manager. Turing immediately raised the price to $750 a tablet f… http://mylifeisworthit.org/blog/2015/09/drug-goes-1350-tablet-750-overnight/

Kids' Vaccines Cut Healthcare Use - Dramatic drop seen in admissions for pneumonia, rotavirus

SAN DIEGO -- Childhood vaccines affect individual disease risk, but they also can have a dramatic impact on the use of healthcare, a researcher said here.
And if one vaccine is good, two can be even better, argued Ron Dagan, MD, of Israel's Ben-Gurion University. The introduction of pneumococcal and rotavirus vaccines in Israel… http://mylifeisworthit.org/blog/2015/09/kids-vaccines-cut-healthcare-use-dramatic-drop-seen-admissions-pneumonia-rotavirus/

One Biotech CEO's Plan To Slash The Cost Of Cancer Immunotherapy

New immune-boosting drugs like Merck ’s Keytruda and Bristol-Myers Squibb BMY +1.61%’s Opdivo are changing the game for cancer patients, but their six-figure-per-year price tags have raised eyebrows among payers worldwide. Those cost concerns…
Earlier this year, Curis partnered with India-based Aurigene to develop several drugs, including one with a similar mechanism of action to Keytruda (pembrolizumab)‎ and Opdivo (n… http://mylifeisworthit.org/blog/2015/09/one-biotech-ceos-plan-slash-cost-cancer-immunotherapy/

« Previous 123456...9 Next »